Golcadomide + R-CHOP in High-Risk, Untreated Aggressive B-Cell Lymphoma - Panel Discussion on Future of 1L Therapy in DLBCL | VuMedi

Find latest DLBCL videos · 200+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Moffitt Cancer Center

Golcadomide + R-CHOP in High-Risk, Untreated Aggressive B-Cell Lymphoma - Panel Discussion on Future of 1L Therapy in DLBCL

By Moffitt Cancer Center FEATURING Yumeng Zhang, Bijal Shah, Julio Chavez, Michael Jain, Sameh Gaballa

By Moffitt Cancer Center FEATURING Yumeng Zhang, Bijal Shah, Julio Chavez, Michael Jain, Sameh Gaballa

109 views

March 6, 2025

Comments 0

Login to view comments. Click here to Login